- Home
- / Impax Laboratories
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Impax Laboratories financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$18.3
2018-05-04
Market Capitalization
$1.4 B
2018-05-04
Revenue
$775.8 M
FY, 2017
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 512.9M | 581.7M | 511.5M | 596.0M | 860.5M | 824.4M | 775.8M |
| Revenue growth, % | 16.5% | 44.4% | -4.2% | ||||
| Cost of goods sold | 254.6M | 299.1M | 312.2M | 283.4M | 508.1M | 486.9M | 535.1M |
| Gross profit | 258.3M | 282.6M | 199.3M | 312.7M | 352.4M | 337.5M | 240.7M |
| Gross profit margin, % | 50.4% | 48.6% | 39.0% | 52.5% | 41.0% | 40.9% | 31.0% |
| General and administrative expense | 68.5M | 108.5M | 120.3M | 139.4M | 201.3M | 201.8M | 216.3M |
| Operating expense total | 158.7M | 199.6M | 205.7M | 223.8M | 282.8M | 343.1M | 546.5M |
| EBIT | 99.6M | 83.0M | (6.4M) | 88.8M | 69.6M | (494.2M) | (402.7M) |
| EBIT margin, % | 19.4% | 14.3% | -1.2% | 14.9% | 8.1% | -59.9% | -51.9% |
| Interest income | 1.1M | 1.1M | 1.3M | 1.5M | 1.0M | 1.0M | |
| Interest expense | 157.0K | 632.0K | |||||
| Pre tax profit | 98.0M | 83.3M | 146.9M | 90.6M | 59.4M | (576.3M) | (451.0M) |
| Income tax expense | 32.6M | 27.4M | 45.7M | 33.2M | 20.4M | (104.3M) | 18.3M |
| Net Income | 65.5M | 55.9M | 101.3M | 57.4M | 39.0M | (472.0M) | (469.3M) |